Product Image

Contributor Information

  • Name Ayham Alnabulsi
  • Institute Vertebrate Antibodies Limited

Tool Details

  • Tool name: Anti-MMP3 [1B4]
  • Clone: 1B4
  • Tool type: Antibodies
  • Tool sub-type: Primary antibody
  • Class: Monoclonal
  • Conjugate: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; IHC ; IF ; IP ; WB
  • Strain: Balb/c
  • Description: Human matrix metalloproteinase 3 (MMP-3) is a member of the matrix metalloproteinases (MMP) family that are peptidases involved in the breakdown of extracellular matrix proteins. MMP-3 degrades fibronectin, laminin, gelatins of type I, III, IV, and V; collagen of type II, III, IV, X, and IX, and proteoglycans. In addition, MMP-3 can also activate other MMPs such as MMP-1, MMP-7, and MMP-9, rendering MMP-3 crucial in connective tissue remodeling. The enzyme is also thought to be involved in wound repair, progression of atherosclerosis, and tumor initiation.
  • Immunogen: Ovalbumin-conjugated synthetic peptide; CKSLRKLEPELH
  • Isotype: IgG1
  • Research area: Cell biology; Cancer; Tissue-specific biology; Genetics
  • Myeloma used: P3X63Ag8.653

  • For Research Use Only

Target Details

  • Target: Human matrix metalloproteinase 3 (MMP-3)
  • Target background: Human matrix metalloproteinase 3 (MMP-3) is a member of the matrix metalloproteinases (MMP) family that are peptidases involved in the breakdown of extracellular matrix proteins. MMP-3 degrades fibronectin, laminin, gelatins of type I, III, IV, and V; collagen of type II, III, IV, X, and IX, and proteoglycans. In addition, MMP-3 can also activate other MMPs such as MMP-1, MMP-7, and MMP-9, rendering MMP-3 crucial in connective tissue remodeling. The enzyme is also thought to be involved in wound repair, progression of atherosclerosis, and tumor initiation.

Application Details

  • Application: ELISA ; IHC ; IF ; IP ; WB

Handling

  • Format: Liquid
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -80°C
  • Shipping conditions: Shipping at 4°C

Documentation

Related Tools

Product Image

Anti-Cisplatin modified DNA [CP9/19]

#151464
Product Image

Anti-TNFRSF18 (soluble form) [T10P2H9*B9]

#153188
Product Image

Anti-APC4 [CIV1.1]

#151500

References

  • •  Jeffery et al. 2009. Histopathology. 54(7):820-8. PMID: 19635101.
  • •  The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers.
  • •  Lyall et al. 2006. Clin Cancer Res. 12(4):1184-91. PMID: 16489072.
  • •  Profiling markers of prognosis in colorectal cancer.
  • •  Curran et al. 2004. Clin Cancer Res. 10(24):8229-34. PMID: 15623598.
  • •  Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
  • •  Murray et al. 1998. Gut. 43(6):791-7. PMID: 9824606.
  • •  Matrix metalloproteinases and their inhibitors in gastric cancer.
  • •  Murray et al. 1998. J Pathol. 185(3):256-61. PMID: 9771478.
  • •  Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.